Long-term outcomes of the pentaspline pulsed-field ablation catheter for the treatment of paroxysmal atrial fibrillation: results of the prospective, multicentre FARA-Freedom Study.
Andreas MetznerMartin FialaJohan VijgenAlexandre OussMelanie A GunawardeneJim HansenJosef KautznerBoris SchmidtMattias DuytschaeverTobias ReichlinYuri BlaauwPhilipp SommerAnnelies VanderperAnitha B AchyuthaMadeline JohnsonJonathan D RaybuckPetr NeužilPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2024)
Clinical Trials.gov Identifier: NCT05072964 (sponsor: Boston Scientific Corporation).
Keyphrases
- atrial fibrillation
- clinical trial
- catheter ablation
- left atrial
- oral anticoagulants
- heart failure
- left atrial appendage
- study protocol
- direct oral anticoagulants
- cross sectional
- percutaneous coronary intervention
- combination therapy
- ultrasound guided
- open label
- left ventricular
- acute coronary syndrome
- smoking cessation